Skip to content

LSD: all studies

Page 59 of 282: studies 581 to 590 of 2,815, newest first. Back to the LSD overview

Research

Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.

Psychopharmacology October 1995 David Fiorella, R A Rabin, Jerrold C Winter

In the context of animal studies of hallucinogens, an LSD-false positive is defined as a drug known to be devoid of hallucinogenic activity in humans but which nonetheless fully mimics LSD in animals. Quipazine, MK-212, lisuride, and yohimbine have all been reported to be LSD false positives. The present study was designed to determine whether these compounds also substitute for the stimulus...

The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion.

Psychopharmacology October 1995 David Fiorella, Scott Helsley, D S Lorrain et al.

The present study was designed to determine the effects of p-chlorophenylalanine (PCPA) and p-chloroamphetamine (PCA) administration on (1) the levels of serotonin (5-hydroxytryptamine, 5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) in rat brain, (2) the sensitivity of LSD-trained rats to the stimulus effects of LSD, and (3) the maximal levels of 5-HT2A and 5-HT2C receptor mediated...

Complex stimulus properties of LSD: a drug discrimination study with alpha 2-adrenoceptor agonists and antagonists.

Psychopharmacology August 1995 D Marona-Lewicka, D E Nichols

The influence of several alpha 2-adrenergic agents on the discriminative stimulus (DS) properties of lysergic acid diethylamide (LSD) was studied in rats trained to discriminate 0.08 mg/kg (186 nmol/kg) of LSD from saline in a two-lever operant paradigm. Only yohimbine fully mimicked LSD with an ED50 of 2.05 mg/kg (5.24 mumol/kg). Yohimbine's 5-HT1A agonist properties may be responsible for...

Catatonia LSD Induced?

Australian & New Zealand Journal of Psychiatry June 1, 1995 K. M. H. Perera, A. Ferraro, M. R. M. Pinto 11 citations

The case of a patient who developed catatonia one week following Lysergic Acid Diethylamide (LSD) ingestion is presented. The psychosis developed two days after the intake. The catatonic syndrome resolved dramatically following one treatment of electroconvulsive therapy (ECT). This is perhaps the first case report of catatonia following the use of LSD. The need for a diagnostic category of...

LSD. Its rise, fall, and renewed popularity among high school students.

Pediatric Clinics of North America April 1, 1995 R H Schwartz

LSD is making a comeback nationwide among Caucasian middle-class high school and college students. Compared to the mean values during the years 1985 to 1990, an approximately 25% increase occurred in lifetime-, annual-, and monthly-use rates of LSD, in 1993, according to the annual NIDA high school senior survey. In 1992, an increase in LSD-related arrests occurred, as did seizures of larger...

LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors.

Psychopharmacology April 1995 V J Watts, C P Lawler, D R Fox et al.

The hallucinogenic effects of lysergic acid diethylamide (LSD) have been attributed primarily to actions at serotonin receptors. A number of studies conducted in the 1970s indicated that LSD also has activity at dopamine (DA) receptors. These latter studies are difficult to interpret, however, because they were completed before the recognition of two pharmacologically distinct DA receptor...

LSD: still with us after all these years

Choice Reviews Online April 1, 1995 22 citations

The facts about LSD A new book on LSD is long overdue, but this was worth waiting for. The material is thoughtful and carefully prepared, and the collection brings the topic into the 1990s. The book should be in every library, and read by everyone interested in the American drug scene. --James A. Inciardi, Ph.D., professor and director, Center for Drug and Alcohol Studies, University of...

Stereoselective LSD-like Activity in a Series of d-Lysergic Acid Amides of (R)- and (S)-2-Aminoalkanes

Journal of Medicinal Chemistry March 1, 1995 Aaron Monte, Danuta Marona‐lewicka, Arthi Kanthasamy et al. 25 citations

The 3-pentyl-, (R)- and (S)-2-pentyl-, 2-hexyl-, and 2-heptylamides of d-lysergic acid were synthesized and evaluated in biochemical and behavioral assays for LSD-like activity. In radioligand competition studies, the (R)-lysergamides were consistently more potent than the (S)-amides in displacing [3H]ketanserin from 5-HT2A receptors in rat cortical homogenate and in displacing [3H]-8-OH-DPAT...

DOI: 10.1021/jm00006a015 (opens in new tab) Lysergic acid diethylamide Stereochemistry Stereoselectivity Carboxamide +3

LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.

The Journal of Pediatrics November 1, 1994

Two adolescents with a long history of abuse of lysergic acid diethylamide (LSD) and symptoms consistent with major depressive disorder, on initiation of antidepressant therapy with selective serotonin reuptake inhibitor agents, had the new onset or worsening of LSD flashback syndrome. The similarity in neuroreceptor physiology for both LSD and serotonin suggests that the LSD flashback syndrome...

Interactions of clozapine with the stimulus effects of DOM and LSD.

Pharmacology, Biochemistry, and Behavior September 1994 P A Palumbo, Jerrold C Winter

Two groups of rats were trained with the 5-HT2 agonists 2,5-dimethoxy-4-methylamphetamine (DOM) or lysergic acid diethylamide (LSD) in a two-lever discrimination task. Tests of generalization and antagonism were then carried out with clozapine. DOM did not generalize to clozapine. Partial antagonism of DOM was observed with 0.3, 1, and 2 mg/kg clozapine and statistically significant full...